Navigation Links
ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
Date:2/20/2008

HALIFAX, Feb. 20 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today the appointment of former senator, Michael Kirby, as the new Board of Directors Chair. Michael Kirby succeeds the late Dr. Warrick Kimmins, who provided exemplary leadership during his tenure and was instrumental in spinning out IVT's novel technology from Dalhousie University.

"I am passionate about advancing health care and am delighted to be part of such a fast-growing biotech company," said former senator Michael Kirby. "IVT has an impressive track record and its patented technology holds tremendous potential to improve vaccines worldwide. "

"Michael Kirby is an internationally respected leader in health care," said Dr. Randal Chase, IVT President and CEO. "His strategic advice will be invaluable, as we enter the next phase of development with the expectation of beginning a new Phase 1 clinical trial in 2009."

The Honourable Michael Kirby has had a distinguished career spanning academia, business, provincial, and federal public service. Most recently, he was appointed, by Prime Minister Stephen Harper, to be the first Chair of the Mental Health Commission of Canada. He also serves on several boards including The Bank of Nova Scotia, Extendicare, Ontario Energy Savings Income Trust, MDC Partners, and Indigo Books and Music.

Senator Kirby was past chair of the Standing Senate Committee on Social Affairs, Science and Technology. He has been a member of the Trilateral Commission, the Council of the International Institute for Applied Systems Analysis, Luxemburg, Austria, and the Club of Rome. He was also a full-time professor in the School of Business Administration and the School of Public Administration at Dalhousie University.

About IVT

ImmunoVaccine Technologies Inc. is a private, clinical-stage, vaccine development company. Through its own biotech research and collaborations with partners, IVT cre
'/>"/>

SOURCE ImmunoVaccine Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board
2. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
3. NASA MidSTAR-1 successful technologies may be revolutionary
4. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
5. Neurobiological Technologies Sets Date for Research and Development Day
6. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc.
7. Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations
8. Emisphere Technologies to Web Cast BIO CEO & Investor Conference Presentation February 12
9. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
10. Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ... Major Weapon in the Battle Against Cancer
11. Genelabs Technologies to Present at the BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DC....D., has stepped down from his position as a direc...r. Lewis advised the Company that his decision to ...commitments to new leadership positions. , , ...81118/NY46990LOGO ) , , Dr. Harold Koplewic...
(Date:12/4/2008)...e-FirstCall/ -- ExonHit Therapeutics S.A.,(Altern...ny, is pleased to,announce today that it has been...strial Property) during the last edition of its "T... "Since its inception, ExonHit consistently ma...f its intellectual property and in particular from...
(Date:12/3/2008).... 3 GlaxoSmithKline,(LS... a condition relating to a,pending lawsuit in the... of,the outstanding shares of common stock of Gen...1.30 per share in cash without interest and less a...ondition to the completion of the tender offer tha...
(Date:12/3/2008)...FirstCall/ -- Advanced Life Sciences Holdings,In.... Food and Drug,Administration (FDA) has accepted...A) for cethromycin, a novel once-a-day oral antibi...nity acquired pneumonia (CAP). The FDA has,estab...hat the anticipated,target action date of the cet...
Breaking Biology Technology:Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors 2ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 2ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 3GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 2GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 3Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia 2Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia 3
...s will receive state grants under the Department o...m, the governor,s office said on Monday: , , Inviv... grant writing. Developing tests to measure physio... LLC, Milwaukee: $6,000 for planning and grant wri... communication. Not to be confused with Esker Soft...
...is intented to be for cancers what the Human Genom...ntists better distinguish different types of cance...hat are more likely to work on patients with parti...plans. , ,National agencies are starting with a pi...er the next three years to study a sampling of tum...
...h Madison has made a deal with Georgia-based Cell...dison, the deployment will not be an overnight eve...others, starting with a 9-square-mile area around ... Council in January and brought online in March. ,...le in brokering Cellnets access to city property a...
...d Wave Technologies, former vice president Kevin C...CEO. John Puisis, who was CEO since mid-2004 and p...y, has resigned. , ,"I came to Third Wave and stay...ment. "With a new business model and an upgraded, ...ose has been completed." , ,Third Wave is one of t...
Other Biology Technology:Madison wireless deal goes forward with Cellnet 2
(Date:12/3/2008)...ion of Oceanography at UC San Diego returning from...ecedented details of vibrant sea life and ecosyste...ions of new species and marine animals previously ...ded surveys at unexplored depths, have revealed di...ence that human impacts have stretched down deeply...
(Date:12/3/2008)... corrective gene into mouse blood cells, scientist...leviated sickle cell disease pathology. In their s...e showed essentially no difference from normal mic...he gene therapy to humans presents significant tec...y will become an important treatment for the disea...
(Date:12/3/2008)...ated how a technique using lasers could be employe... campaign supports one of the main objectives of t...-SCOPE (Advanced Space Carbon and climate Observat...arth Explorer missions that has just completed ass... other five, will be presented to the science comm...
(Date:12/3/2008)...oday, the International Society for Stem Cell Rese...anization of stem cell researchers, released new g...and effective stem cell therapies for patients. A ...for the Clinical Translation of Stem Cells will be... Cell Stem Cell , the official affiliated journal ...
Breaking Biology News(10 mins):Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 2Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 4Gene therapy corrects sickle cell disease in laboratory study 2Gene therapy corrects sickle cell disease in laboratory study 3ESA tests laser to measure atmospheric carbon dioxide 2ESA tests laser to measure atmospheric carbon dioxide 3The International Society for Stem Cell Research releases new guidelines 2The International Society for Stem Cell Research releases new guidelines 3Winemaking waste proves effective against disease causing bacteria in early studies 8971 1Winemaking waste proves effective against disease causing bacteria in early studies 8971 2Winemaking waste proves effective against disease causing bacteria in early studies 8971 3Winemaking waste proves effective against disease causing bacteria in early studies 8971 4Tips to prevent adverse drug events in older adults 8966 1Tips to prevent adverse drug events in older adults 8966 2Tips to prevent adverse drug events in older adults 8966 3Evolution education is a must says coalition of scientific and teaching organizations 1753 1Evolution education is a must says coalition of scientific and teaching organizations 1753 2Use of opioids for pain in ERs on the rise but racial differences in use still exist 8961 1Use of opioids for pain in ERs on the rise but racial differences in use still exist 8961 2Use of opioids for pain in ERs on the rise but racial differences in use still exist 8961 3
...ospective study in the Canadian Medical Associatio...arly boys, are about twice as likely as the total ...an injury. , Brison and colleagues collected and a...es to young children to determine rates, identify ... and ranches. They found that children 1? years ol...
... at the Umeå Plant Science Centre (UPSC) and the S...eport today about a breakthrough in our understand...ees is controlled. In an article published in the ...FT gene that was previously shown to control the f... flowering. , With the help of this gene poplar t...
...tudy could potentially help researchers find new w...nd enhance the potency of existing drug compounds....an advance online edition of the journal Science, ...reat infectious disease is being seriously undermi...says Geoffrey A. Chang, Ph.D., a Scripps Research ...
...mes to fire ants, most people prefer to wipe the v...?or at least out of their own back yards. The revi...n Belt via 1940s Mobile, Ala., is known in biology... as a painful pest in the grass, so to speak. , Th...ant fan and one of its foremost researchers for mo...
Other Biology News:Important gene controlling tree growth and development found 2Important gene controlling tree growth and development found 3New study reveals structure of E. coli multidrug transporter protein 2New study reveals structure of E. coli multidrug transporter protein 3Fire ants: Their true story told by the scientist who loves them 2Fire ants: Their true story told by the scientist who loves them 3
100 adhesive strips.
Homo sapiens palladin
Mouse P-Selectin/CD62P MAb (Clone 127933)
Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@
Biology Products: